These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14751580)

  • 1. Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.
    Ng AH; Hercz G; Kandel R; Grynpas MD
    Bone; 2004 Jan; 34(1):216-24. PubMed ID: 14751580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients.
    D'Haese PC; Couttenye MM; Lamberts LV; Elseviers MM; Goodman WG; Schrooten I; Cabrera WE; De Broe ME
    Clin Chem; 1999 Sep; 45(9):1548-56. PubMed ID: 10471660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
    Joffe P; Heaf JG; Jensen C
    Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.
    Goodman WG; Duarte ME
    Miner Electrolyte Metab; 1991; 17(4):221-32. PubMed ID: 1813784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal osteodystrophy in pre-dialysis patients: ethnic difference?
    Shin SK; Kim DH; Kim HS; Shin KT; Ma KA; Kim SJ; Kwak YS; Ha SK; Sherrard DJ
    Perit Dial Int; 1999; 19 Suppl 2():S402-7. PubMed ID: 10406554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.
    Wang M; Hercz G; Sherrard DJ; Maloney NA; Segre GV; Pei Y
    Am J Kidney Dis; 1995 Nov; 26(5):836-44. PubMed ID: 7485142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function.
    Hercz G; Pei Y; Greenwood C; Manuel A; Saiphoo C; Goodman WG; Segre GV; Fenton S; Sherrard DJ
    Kidney Int; 1993 Oct; 44(4):860-6. PubMed ID: 8258962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
    Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
    J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
    Hernandez D; Concepcion MT; Lorenzo V; Martinez ME; Rodriguez A; De Bonis E; Gonzalez-Posada JM; Felsenfeld AJ; Rodriguez M; Torres A
    Nephrol Dial Transplant; 1994; 9(5):517-23. PubMed ID: 7522307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
    Gal-Moscovici A; Popovtzer MM
    Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy.
    Libbey NP; Chazan JA; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1993 Apr; 39(4):214-23. PubMed ID: 8491052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of renal osteodystrophy in Iberoamerica.
    Jorgetti V; López BD; Caorsi H; Ferreira A; Palma A; Menendez P; Douthat W; Olaizola I; Ribeiro S; Jarava C; Moreira E; Cannata J
    Am J Med Sci; 2000 Aug; 320(2):76-80. PubMed ID: 10981479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.